53. Abbott Laboratories 2012 ($1,499 million)
Abbott Laboratories pleaded guilty to misbranding epilepsy, bipolar disorder and migraine prevention drug Depakote in 2012, and paid US$1.5 billion in total.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.